Use of co-primary outcomes for trials of antimicrobial stewardship interventions

The Lancet Infectious Diseases

Volumn 18, Issue 6, 2018, Pages 595-597

  Gillespie, David ^a   Francis, Nick A ^a   Carrol, Enitan D ^b   Thomas Jones, Emma ^a   Butler, Christopher C ^c   Hood, Kerenza ^a  

^a CARDIFF UNIVERSITY   (United Kingdom)

^b UNIVERSITY OF LIVERPOOL   (United Kingdom)

^c UNIVERSITY OF OXFORD   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; C REACTIVE PROTEIN; PROCALCITONIN; ANTIINFECTIVE AGENT;

ANTIBIOTIC RESISTANCE; ANTIMICROBIAL STEWARDSHIP; BACTERIAL INFECTION; CAUSE OF DEATH; CHRONIC OBSTRUCTIVE LUNG DISEASE; CLINICAL ASSESSMENT; CLINICAL EFFECTIVENESS; CLINICAL OUTCOME; DISEASE EXACERBATION; DRUG SAFETY; EFFECT SIZE; EVIDENCE BASED PRACTICE; HEALTH STATUS; HOSPITAL READMISSION; HUMAN; INTERVENTION STUDY; LONG TERM CARE; MANAGED CARE; NOTE; NULL HYPOTHESIS; OUTCOME ASSESSMENT; POINT OF CARE TESTING; PRESCRIPTION; PRIORITY JOURNAL; PUBLIC HEALTH; RETREATMENT; SAMPLE SIZE; SECONDARY HEALTH CARE; DRUG UTILIZATION;

ANTI-INFECTIVE AGENTS; ANTIMICROBIAL STEWARDSHIP; DRUG RESISTANCE, BACTERIAL; DRUG UTILIZATION; HUMANS;

EID: 85047248878     PISSN: 14733099     EISSN: 14744457     Source Type: Journal    
DOI: 10.1016/S1473-3099(18)30289-5     Document Type: Note

References (9)

1. HO. Antimicrobial resistance: global report on surveillance. 2014, World Health Organization, Geneva http://apps.who.int/iris/bitstream/handle/10665/112642/9789241564748_eng.pdf?sequence=1. (Accessed 23 February 2018)
2. Goossens, H, Ferech, M, Vander Stichele, R, Elseviers, M, Outpatient antibiotic use in Europe and association with resistance: a cross-national database study. Lancet 365 (2005), 579–587.
3. Costelloe, C, Metcalfe, C, Lovering, A, Mant, D, Hay, AD, Effect of antibiotic prescribing in primary care on antimicrobial resistance in individual patients: systematic review and meta-analysis. BMJ, 340, 2010, c2096.
4. Davey, P, Marwick, CA, Scott, CL, et al. Interventions to improve antibiotic prescribing practices for hospital inpatients. Cochrane Database Syst Rev, 2, 2017 CD003543.
5. Aldeyab, MA, Scott, MG, Kearney, MP, et al. Impact of an enhanced antibiotic stewardship on reducing methicillin-resistant Staphylococcus aureus in primary and secondary healthcare settings. Epidemiol Infect 142 (2014), 494–500.
6. Cosby, JL, Francis, N, Butler, CC, The role of evidence in the decline of antibiotic use for common respiratory infections in primary care. Lancet Infect Dis 7 (2007), 749–756.
7. Oczkowski, S, Antimicrobial stewardship programmes: bedside rationing by another name?. J Med Ethics 43 (2017), 684–687.
8. Offen, W, Chuang-Stein, C, Dmitrienko, A, et al. Multiple co-primary endpoints: medical and statistical solutions: a report from the multiple endpoints expert team of the pharmaceutical research and manufacturers of America. Drug Inf J 41 (2007), 31–46.
9. Bates, J, Francis, NA, White, P, et al. General practitioner use of a C-reactive protein point-of-care test to help target antibiotic prescribing in patients with acute exacerbations of chronic obstructive pulmonary disease (the PACE study): study protocol for a randomised controlled trial. Trials, 18, 2017, 442.